IFLR1000

Iterum Therapeutics Nasdaq IPO

31/5/2018
IPO
Select tab

$ 80 million

Completed

31/5/2018

Overview:

  • Irish pharmaceutical company Iterum Therapeutics has undergone an IPO on the NASDAQ stock exchange.
  • The 6,150,000 ordinary shares were listed to the public at a price of $13 per share. 

Rajeeb Gurung - Researcher

Jurisdictions:

United States
Ireland

Deal type:

IPO

Practice area:

Capital markets : Equity

Industry sector:

Pharmaceuticals and life sciences

Firms:
A&L Goodbody

Party: Iterum Therapeutics (Issuer)

Lawyers: Alan Casey, Keavy Ryan

Cooley

Party: Iterum Therapeutics (Issuer)

Davis Polk & Wardwell

Party: Leerink Partners (Joint book-running managers)

Party: RBC Capital Markets (Joint book-running managers)

Party: Guggenheim Securities (Lead manager)

Party: Needham & Company (Co-manager)

Related deals